跳至主要内容
临床试验/NCT04215861
NCT04215861Unknown不适用

Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy

The First Affiliated Hospital of Dalian Medical University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
Raman spectra

研究概览

简要总结

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral.

详细描述

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-80 years old;
  • The patient whose tumor (tissue or cell) was first diagnosed by pathology;
  • Plan to receive routine clinical treatment: chemotherapy, radiotherapy, surgery, intervention, targeted therapy, traditional Chinese medicine treatment and biological immunotherapy;
  • Have relevant indications for treatment and have no contraindications;

排除标准

  • Severe or uncontrollable systemic diseases (such as unstable or uncompensated respiratory, heart, liver or kidney diseases, etc.);
  • Other circumstances considered inappropriate by the researcher to participate in the study;

结局指标

主要结局

Raman spectra

时间窗: the 1st day after operation

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected to analyze the signal changes of Raman spectrum

次要结局

  • overall survival(through study completion, an average of 1 year)
  • progression-free survival(through study completion, an average of 1 year)
  • objective response rate(through study completion, an average of 1 year)

研究者

发起方
The First Affiliated Hospital of Dalian Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验